Search results
Results from the WOW.Com Content Network
Esketamine is the second drug to be approved for TRD by the FDA, following olanzapine/fluoxetine (Symbyax) in 2009. [25] [50] Other agents, like the atypical antipsychotics aripiprazole (Abilify) and quetiapine (Seroquel), have been approved for use in the adjunctive therapy of MDD in people with a partial response to treatment. [25]
The PDUFA date thus serves as a 'best estimate' of when a decision on a New Drug Application or a Biologics License Application would be forthcoming. This response may be a decision to approve the application or a Complete Response Letter (CRL). The PDUFA date may be extended by the Food and Drug Administration in certain circumstances. [6]
A fee is required to make such FDA submission. For financial year 2020, this fee was: for an application requiring clinical data ($2,942,965) and for an application not requiring clinical data ($1,471,483). [4] A team of CDER physicians, statisticians, chemists, pharmacologists, and other scientists reviews the company's data and proposed labeling.
After the publication of the NIH-run antidepressant clinical trial, clinics began opening in which the intravenous ketamine is given for depression. [5] [6] This practice is an off label use of IV ketamine in the United States, though the intranasal version of esketamine has been approved by the FDA for treatment of depression [5] [7] In 2015 there were about 60 such clinics in the US; the ...
Lykos Therapeutics is cutting 75% of staff after FDA rejected its MDMA drug for mental health. The FDA's decision marks the first time the agency considered a psychedelic for medical use.
The FDA has not yet taken action on the petition, and it’s unclear what impact granting it would have on the availability of the other vaccines that protect against polio.
The letter described what was required by the FDA. [3] Applicants had 10 days after the date of the approvable letter to amend the application, notify of intent to file for an extension, withdraw the application, request a hearing or notify that they agreed to an extension. [3]
Robert F. Kennedy Jr.'s lawyer has petitioned the FDA to revoke its approval of the inactivated poliovirus vaccine, which is widely considered to be safe and effective. (Ed Jones/AFP/Getty Images ...